These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Flavonoids and the cardiovascular system: can they be a therapeutic alternative?]. Tenorio López FA; del Valle Mondragón L; Pastelín Hernández G Arch Cardiol Mex; 2006; 76 Suppl 4():S33-45. PubMed ID: 17469333 [TBL] [Abstract][Full Text] [Related]
3. Statins for the primary prevention of cardiovascular events in elderly patients: a picture from clinical practice without strong evidence from clinical trials. Trifirò G; Alacqua M; Corrao S; Tari M; Arcoraci V J Am Geriatr Soc; 2008 Jan; 56(1):175-7. PubMed ID: 18184214 [No Abstract] [Full Text] [Related]
4. Does surveillance impact on cardiovascular prevention? Di Chiara A; Vanuzzo D Eur Heart J; 2009 May; 30(9):1027-9. PubMed ID: 19228712 [No Abstract] [Full Text] [Related]
5. [Role of tea flavonoids in cardiovascular protection]. de Luis DA; Aller R An Med Interna; 2008 Mar; 25(3):105-7. PubMed ID: 18560675 [No Abstract] [Full Text] [Related]
7. Cardiovascular disease and differences between the sexes. Johnson BE; Johnson CA Am Fam Physician; 2001 Apr; 63(7):1290, 1292. PubMed ID: 11310645 [No Abstract] [Full Text] [Related]
8. Therapy and clinical trials: diabetes and cardiovascular risk. Peter R Curr Opin Lipidol; 2008 Feb; 19(1):101-3. PubMed ID: 18196995 [No Abstract] [Full Text] [Related]
9. Bibliography. Current world literature. Therapy and clinical trials. Curr Opin Lipidol; 2002 Dec; 13(6):671-2. PubMed ID: 12523337 [No Abstract] [Full Text] [Related]
10. Observational data and clinical trials: narrowing the gap? Wilcox A; Wacholder S Epidemiology; 2008 Nov; 19(6):765. PubMed ID: 18854701 [No Abstract] [Full Text] [Related]
11. Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill? Wienbergen H; Senges J; Gitt AK Diabetes Care; 2008 Feb; 31 Suppl 2():S222-5. PubMed ID: 18227489 [No Abstract] [Full Text] [Related]
12. Therapy insight: Management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy. Khakoo AY; Yeh ET Nat Clin Pract Oncol; 2008 Nov; 5(11):655-67. PubMed ID: 18797437 [TBL] [Abstract][Full Text] [Related]
13. [What future for cardiovascular prevention trials?]. Scheen AJ Rev Med Suisse; 2009 Aug; 5(214):1635-6. PubMed ID: 19772193 [No Abstract] [Full Text] [Related]
14. Clinical trials of antioxidant supplementation in the prevention of cardiovascular events. Katsiki N; Manes C Arch Intern Med; 2008 Apr; 168(7):773; author reply 773-4. PubMed ID: 18413563 [No Abstract] [Full Text] [Related]
15. The ADVANCE trial: further PROGRESS with HOPE. Karthikeyan VJ; Bakris G; MacFadyen RJ J Hum Hypertens; 2007 Dec; 21(12):911-3. PubMed ID: 17960167 [No Abstract] [Full Text] [Related]
19. [Metabolic alterations, AIDS and vascular disease]. Betancor León P An Med Interna; 2007 Apr; 24(4):157-9. PubMed ID: 17867897 [No Abstract] [Full Text] [Related]
20. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. Benavente-García O; Castillo J J Agric Food Chem; 2008 Aug; 56(15):6185-205. PubMed ID: 18593176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]